047920 — HLB Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for HLB Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25,545	24,624	25,874	10,492	9,147
Net Total Accounts Receivable
Net Total Receivables	13,373	16,808	18,351	17,005	23,868
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	51,468	59,946	71,575	63,381	76,702
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	53,954	51,612	48,358	34,020	44,388
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	127,632	142,177	141,352	157,933	170,682
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	45,507	52,857	48,896	38,632	39,628
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	49,248	56,249	53,198	41,532	45,534
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	78,385	85,929	88,153	116,402	125,149
Total Liabilities & Shareholders' Equity	127,632	142,177	141,352	157,933	170,682
Total Common Shares Outstanding